gao_reports: GAO-26-107691

Government Accountability Office reports (1994–2008) with abstracts, legal references, and subject classifications.

This data as json

package_id	title	date_issued	report_number	document_type	doc_class	abstract	subjects	public_laws	usc_references	statute_references	citation	pdf_url	html_url	detail_url	sudocs
GAO-26-107691	Rare Diseases: Funding for Rare Neurodegenerative Disease Research and Access to ALS Investigational Drugs	2026-02-04	GAO-26-107691			Amyotrophic lateral sclerosis, known as ALS or Lou Gehrig's disease, is a rare and ultimately fatal neurological disorder. Not much is known about how to treat or prevent ALS. We reviewed certain federal funding to advance research on ALS and similar diseases and found: The National Institutes of Health and FDA awarded about $276 million from FY 2022-FY 2025 for research and treatment development Some...								https://www.gao.gov/products/gao-26-107691